chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Fever, vomiting, diarrhea 0.2 days after rotavirus vaccine, fever vomiting, lethargy DX Meningitis 5 days after Rotavirus vaccine. 10/20/06 Received medical records from hospital which reveal patientadmitted 9/3/06-9/29/06 with D/C dx: group B Streptococcus meningitis, s/p craniotomy & abscess drainage on 9/13. HPI: 5 day hx of fever max of 104.5 beginning approx 1 hr s/p vax with Rotateq, lethargy & a 1 hour generalized tonic-clonic seizure on day of admission.    Tx with multiple antibiotics.  Craniotomy on 9/13 for removal of empyema.  No further seizure activity but continued to spike intermittent temps whcih gradually resolved.  Afebrile at D/C but concerns remained about hearing loss & possible developmental sequelae.  MRI was to be repeated as outpatient & she was to continue f/u with PCP. Birth hx: c-section, breech presentation.  Mom possible HIV + by screening. Patient on ZDV for 4 weeks.  Mom GBS neg. LABS: CSF + for group B strep; EEG & CT of head were WNL.  Brain cultures neg. Bone scan neg for osteomyelitis. MRI of brain revealed fluid pockets in bilateral sylvan fissures, more on left.  MRI spine WNL.  Right ear failed audiology exam  x 2.  Repeat MRI showed fluid collection in mastoid air cells. D/C Summary 5 pgs; medical records 170 pgs./ss
Received flu vac 10-12-09. Reports reaction onset eve of 10-12 until 10-14-09. Pt reports nite of 10-12-09 awoke drenched in sweat which lasted 2-3 hours. She does not have a thermometer, but felt feverish. Sore throat and body aches x 36 hours. denied nausea/vomiting, cough or nasal drainage. No soreness or redness @ flu inj site. Assessment: FLu vaccine reaction. Pt is back to baseline.
muscle weakness & chronic pain in muscles, around joint increased drastically;walking is extremely painful;uses a cane;became unable to walk from 1993 to 1998;h/a, swelling;becoming paralyzed;sz;SEP98 myositis, myalgia w/radiculitis;
"Strongly" aching joints, fatigue, on and off headache.  Still with symptoms, except headache, slight cough.  States no prior problems with flu shots.
arm to turn black and blue at the injection site; This case was reported by a other health professional via interactive digital media and described the occurrence of injection site coloration in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced injection site coloration. On an unknown date, the outcome of the injection site coloration was unknown.   It was unknown if the reporter considered the injection site coloration to be related to Shingrix.  Additional details were reported as follows: The age at vaccination was not reported. The reporter stated that the arm turn to black and blue at the injection site.
July 4 , 2020- right-handed weakness with numbness, slurred speak, and had trouble finding words. July 6, 2020 - couldn't move her entire right side of her body and could not speak at all. Hospitalized on July 6, 2020 and determined she had a stroke based on an MRI. Numerous blood tests were taken along with a 2nd MRI with her braces removed.
Fever 102, headache, myalgia, generalized malaise, rash on arm of injection of vaccine.
Pain in Right ear radiated into neck, could not move head without pain and swollen lymph node in right neck.
16Jan91 in evening.Lt arm around inject site became red,swollen,warm to touch & tender.Pt did not want to arm.T went up to 102.4 that night.17Jan91 T nl. Arm remains red,swollen,warm & tender.Pt is moving arm more.
it was rpt pt recv 1st dose of varivax & subsequently pt presented w/``approx 60 lesions'' rpt noted rash atypical to varicella. painful, not pruritic, MD rpt cough, congestion & runny nose w/o fever. subsequently devel rash.
This spontaneous report as received from a pharmacy technician refers to a 1 year old patient of unknown gender. Patient's concurrent conditions, medical history, concomitant medications, drug reactions and allergies were not reported. On 28-FEB-2018, the patient was vaccinated with improperly stored dose of VARIVAX (lot # N022979, expiry 23-AUG-2019) for prophylaxis. No adverse effect was reported. The VARIVAX temperature excursion occurred on 14-DEC-2017 and 30-DEC-2017. On 14-DEC-2017, the vaccine was exposed to the temperature of 16.9 degree Fahrenheit (F) for 30 minutes. On 30-DEC-2017, the vaccine was exposed to the temperature of 6 degree Fahrenheit (F) to 14 degree F for 30 minutes. It was reported that the event was because of data logger. No product quality complaint was involved. This is one of the several reports received from the same reporter source. Sender's Comments: US-009507513-1802USA001558.
11/10 patient found at on the floor unresponsive by family, when EMS arrived it appeared as though the patient had a seizure episode, urinated on himself and mental status was altered/combative. Patient treated in ED and admitted for altered mental status due to being confused and 101.6F. Per chart the patient had a similar reaction to the second dose.   DISCHARGE DIAGNOSIS:   -Acute metabolic encephalopathy, now improved Patient is now at baseline mental state Unclear if this is related to the recent COVID-19 vaccine booster dose Patient was found laying on the floor initially CT brain: Reviewed LP done in the ED - low suspicion for meningitis Initially started on empiric IV Rocephin Stable for discharge home today.  Return if symptoms worsen. Follow-up with primary care physician   -Rhabdomyolysis, improved CK level trended down with IV fluids
I came home, and I went to sleep, and I didnt wake up for two days. When I woke up, it was 11am, I was suppose to be at work, I called in (i went back the day after). Apon returning to work, I could not remember my coworker name that worked in the cube with me. I asked my sup to give me a refresher course, and they told me they did not have time. So throughout that time until Feb 11, 2023, I was put on PIPS. I didnt meet the goal. I had severe memory loss, memory fogg, hair loss, and insomnia, and I developed neuropathy in my left foot.
This is a spontaneous report from a contactable physician. A patient (age and gender unknown) received a "supplemental" dose of PREVNAR13 on an unknown date. Relevant medical history and concomitant medications were not reported. Past product history included primary immunization series (not further specified). On an unknown date,, following administration of PREVNAR13, the patient developed an injection site reaction and their entire arm broke out in hives. At the time of this report, the outcome of the events was unknown. Follow-up (20MAY2011): Follow-up attempts completed. No further information expected.
erythema multiforme rash on face, arms, hands, feet & legs, swelling of both feet;sx began on 26JUN96 in afternoon & pt mom describes rash as being worse on 27JUN96 in the morning;pt was started on DPH & pediapred 27JUN96;
This spontaneous report as received from a pharmacist and a registered nurse refers to a 2 month old patient of unknown gender. On 25-FEB-2014, the patient was vaccinated with an expired dose of ROTATEQ (lot # H012974, expiry date 07-FEB-2014), first dose, 2 ml, orally (indication not reported). No adverse effects reported. It was unspecified if the patient sought medical attention. Additional information has been requested.
PARTIAL DOSE ADMINISTRATION; This spontaneous report received from a pharmacist concerned a 20 year old of unspecified sex. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included the patient had no known allergies. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, and batch number: 1808982 expiry: 23/JUN/2021) dose was not reported, administered on 09-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 09-APR-2021, the subject experienced partial dose administration. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of partial dose administration was not reported. This report was non-serious.
Pt received Flu vaccine 9/24/13 at 11:45 AM return to office at 4 PM. C/O weakness, nausea, throat closing.
Increased Heart Rate, Shortness of Breath, Tinnitus and Rash - chest and trunk area. Started Saturday night. Took a Claritin (did not have Benadryl). Rash went away.  SOB lasted off and on for several days. Heart rate was off when I was working out for a couple of weeks.  I work out  so we wear heart rate monitors.  Heart rate did not recover as quickly as normal during my workouts. Took a couple of weeks for this to get back to normal for me.  Just really felt "off" for awhile and not like myself.  Did not feel comfortable getting second shot because of the above symptoms.
the patient was administered an improperly stored dose of VARIVAX; no adverse effects; This spontaneous report was received from a nurse and refers to a patient of an unknown age and gender. There was no information about the patient's concurrent condition, concomitant medication and medical history provided.  On 24-SEP-2019, the patient was vaccinated with varicella virus vaccine live (oka/merck)(VARIVAX) injection (lot number S002874, expiration date not reported but upon internal validation established as 29-JAN-2021) for prophylaxis (exact dose and route of administration were not reported). The varicella virus vaccine live (oka/merck)(VARIVAX) was reconstituted in properly stored sterile diluent. No adverse effects were reported.  The vaccine experienced temperature excursion of 7.64 degree Fahrenheit for 20 minutes. The previous temperature excursion was 19.34 degree Fahrenheit for 34 minutes. The digital data logger was involved.
Patient stated the he had a normal doppler scan on September 1st.   He received his second Pfizer dose on  9/13.  Roughly twice weeks later, he had pain in his legs and went to his PCP.  Another doppler scan was ordered and it was determined that he had blood clots in both legs.  He has since been treated by a vascular specialist that has him on aspirin 325mg daily.  No other adverse effects were reported when he stopped in today and shared this information.
Patient's spouse came in after article in newspaper shared that the HIGH DOSE FLU vaccine caused persistent arm pain this year. She said he had arm pain since receiving the vaccine.
Patient said that they started  to experience hearing loss in the left ear a day after getting the vaccine. He said it sounded like the sound of ocean waves. He said he had spoken with drs some of which said that it may be something else causing it. he will see dr i f condition does not improve.
facial numbness/possible migraine (resolved); Hypertension (resolved) Body aches, drowsiness (resolved), neck pain (ongoing, possible fibromyalgia flare); ocular irritation redness (ongoing, possibly unrelated)
Information has been received from a physician concerning a female who on 02-AUG-2007 was vaccinated with a dose of Zostavax (Oka/Merck).  On 03-AUG-2007 at 5 a.m. the patient developed back pain, and went to the local emergency room for unspecified medical attention.  No further information was provided.  There was no product quality complaint involved.  Additional information has been requested.
PRESSURE IN HER HEAD; SOME ACID REFLUX; FELT SUPER BAD; SOME PAIN ALL OVER THE BODY; A LOT OF CHILLS; HEADACHES; HIGH FEVER; This spontaneous report received from a patient concerned a 19 year old female. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine  (suspension for injection, route of admin not reported, batch number: 1805031, and expiry: UNKNOWN) dose was not reported, administered on 12-MAY-2021 for prophylactic vaccination. No concomitant medications were reported. On 12-MAY-2021, the subject experienced pressure in her head. On 12-MAY-2021, the subject experienced some acid reflux. On 12-MAY-2021, the subject experienced felt super bad. On 12-MAY-2021, the subject experienced some pain all over the body. On 12-MAY-2021, the subject experienced a lot of chills. On 12-MAY-2021, the subject experienced headaches. On 12-MAY-2021, the subject experienced high fever. On 13-MAY-2021 03:00:00, treatment medications included: paracetamol. The action taken with covid-19 vaccine  was not applicable. The patient had not recovered from some pain all over the body, headaches, pressure in her head, a lot of chills, high fever, and some acid reflux, and the outcome of felt super bad was not reported. This report was non-serious.
Blood in my stool; Fatigue; Fever; This spontaneous case was reported by a consumer and describes the occurrence of HAEMATOCHEZIA (Blood in my stool) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 31-Aug-2021, the patient experienced FATIGUE (Fatigue) and PYREXIA (Fever). On 01-Sep-2021, the patient experienced HAEMATOCHEZIA (Blood in my stool) (seriousness criterion medically significant). At the time of the report, HAEMATOCHEZIA (Blood in my stool) outcome was unknown and FATIGUE (Fatigue) and PYREXIA (Fever) was resolving.            Concomitant product use was not provided by the reporter. No treatment information was provided.  Very limited information regarding these events have been provided at this time, unknown date of vaccination hence cannot establish temporal relationship. No further information is expected.; Sender's Comments: Very limited information regarding these events have been provided at this time, unknown date of vaccination hence cannot establish temporal relationship. No further information is expected.
FIRST DOSE GIVEN WAS PFIZER VACCINE (6/7/21), SECOND DOSE WAS MODERNA (7/22/21).   PATIENTS CARD WAS FILLED OUT INCORRECTLY ON FIRST DOSE. PFIZER WAS ADMINISTERED BUT CARD SAID MODERNA SO WHEN PATIENT CAME FOR 2ND DOSE, MODERNA WAS ADMINISTERED.   CDC WEBSITE STATES THAT THIS VACCINATION ERROR (MIXING VACCINES) SHOULD BE REPORTED.
The following evening, I began to have pain in my gallbladder.  and it was sensitive to the touch, so I believe it was inflamed.  I do not have chronic gall.bladder issues, and I woke up the next morning with no more issues.  So, I do believe it was an effect of the vaccine.
Hives to opposite arm starting the same day of vaccine, hives continuing to spread over arms, back, and buttocks 2 weeks from injection date. Currently controlled with benedryl
Right eye chalazion; low-grade fever; This spontaneous case was reported by a consumer and describes the occurrence of CHALAZION (Right eye chalazion) and PYREXIA (low-grade fever) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037A21B) for COVID-19 vaccination.     Concurrent medical conditions included Asthma. Concomitant products included ATORVASTATIN and FLUTICASONE PROPIONATE, SALMETEROL XINAFOATE (WIXELA INHUB) for an unknown indication.   On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 15-Mar-2021, the patient experienced PYREXIA (low-grade fever). On 21-Apr-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced CHALAZION (Right eye chalazion). The patient was treated with DEXAMETHASONE, TOBRAMYCIN (TOBRAMYCIN + DEXAMETHASONE) at an unspecified dose and frequency and AMOXICILLIN at a dose of 500 mg. At the time of the report, CHALAZION (Right eye chalazion) and PYREXIA (low-grade fever) had resolved.            This case was linked to MOD-2021-086328 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 27-May-2021: Updated reporter details, updated patient demographics, updated medical history, updated concomitant medications, updated treatment medications and changed outcome of the event chalazion from unknown to recovered/resolved.
I took the vaccine and that evening, I felt something going on in my body and brain. I woke up in the middle of the night with my arm numb down to my hand and this went on for around a week.  Within 24 hours I began to feel odd, such as having been on a street drug or something of this nature.  This went on for several weeks. I have never felt this way in my life and have always been completely stable. This vaccine has affected me in a way that is not fully describable. I feel mostly back to myself, at this point, but not fully. I have had a full reaction to this vaccine.  Not sure if I will ever be the same.
Cluster of three patients who each developed symptoms of pertussis after having received ADACEL (lot number C2456AA). Initial report received on 18 October 2011 from a health professional. Three unidentified physicians from the same office each received a first intramuscular injection of ADACEL (lot number C2456AA) on an unspecified day in December 2006. In October 2011, one patient had confirmed B pertussis via IgA/IgM and the other two patients had symptoms of pertussis, for which IgA/IgM blood test results were pending. The patients had not recovered. No other information was provided. Documents held by sender: None.
ITP had vax on 28JAN & 15FEB had t101 followed by slow appearance of red spots & inc bruising; PT/PTT nl; CBC nl x/plts 32,000; sed rate 4; 23FEB plts 104K;
Distal numbness, sensation was diminished, mild associated pinprick sensation. Paraesthesia progressed up her legs and into thighs. Numb feeling in fingertips.
Random heart palpitations, tachycardia, mild chest tightness and occasional fatigue. Started five days post COVID Pfizer vaccine. Symptoms strikes at random times. No prior health issues.
@ 1130AM began coughing which worsened into "croup"-soundng stridor, but fell asleep; When awakened had extreme pallor, "grabbing @ throat & tongue sticking out; "noise" breathing; speech rough & difficult; c/o needing a drink & to throw up
This spontaneous report was received from a registered nurse referring to a patient of currently 65 years of age and unspecified gender. The patient's pertinent medical history and concomitant medications were not reported. On an unknown date, the patient was vaccinated with improperly stored dose of ZOSTAVAX, lot # L035283, expiry date: 15-DEC-2016 (dose, route of administration and anatomical location not reported). The doses of ZOSTAVAX underwent temperature excursion: 14.7F for 2 hours and 15 minutes. There were no previous temperature excursions. No symptoms were reported. No product quality complaint (PQC) was involved. No further information was provided. This is one of several reports from the same reporter. Additional information has been requested.
Comes to clinic as walk-in with c/o non-productive cough with shortness of  breath x 2w after the evening after he got his Pneumovax.  He states he is slightly  short of breath now.  Denies chest pain.  He has hx of MI 2yr ago with placement  of 1 stent.  Abdomen is tight and he states his bowels are moving regularly.  No pedal edemal.  He has gained 3.9# since 3-11-09 with his report of eating the same amount of food.  He states he has a "scratchy throat" and some cough left.  BP 161/117, P-117 with retake 154/118, 84.
CUT HIMSELF WHILE SHAVING; CHEST RASH; SHAKING; HEADACHE; LETHARGIC; ACHEY; This spontaneous report received from a consumer concerned a 53 year old male. The patient's height, and weight were not reported. The patient's concurrent conditions included epilepsy. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805031, and expiry: UNKNOWN) dose was not reported, administered on 04-MAR-2021 to left arm for prophylactic vaccination. Concomitant medications included lamotrigine for epilepsy, and levetiracetam for epilepsy.  On 04-MAR-2021, the subject experienced lethargic. On 04-MAR-2021, the subject experienced achey. On 04-MAR-2021, the subject experienced headache. On 05-MAR-2021, the subject experienced shaking. On 10-MAR-2021, the subject experienced chest rash. On 16-APR-2021, the subject experienced cut himself while shaving. Treatment medications (dates unspecified) included: loratadine, and ibuprofen. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from cut himself while shaving on APR-2021, chest rash on 13-MAR-2021, and headache on MAR-2021, and the outcome of lethargic, achey and shaking was not reported. This report was non-serious.; Sender's Comments: V0: Medical assessment comment was not required as per standard procedure as case assessed as non-serious.
Facial swelling on right side after 1 yr immunizations, MMR 1/Varicella 1/Prevnar 3
lot of pain; feel so woozy; This is a spontaneous report from Pfizer sponsored program, received  from a contactable consumer (patient). An 83-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiration date not provided), via an unspecified route of administration second dose on 14Apr2021 at single dose for covid-19 immunisation. The patient's medical history and concomitant medications were not reported.  The patient historical vaccine includesnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) first dose on an unspecified date for covid-19 immunisation and experienced Adverse event.  It was reported that patient got the second dose on 14Apr2021. The patient mentioned that he got sick very bad that leads him to a hospital, he mentioned that no one came to assist him even the doctors and right now he wants to know if we can help him to file a complaint, he stated that he experienced a lot of pain and feel so woozy. The outcome of the events was unknown.  Information about lot/batch number has been requested.
The day after her second Pfizer covid vaccine, she developed blisters on the tips of her fingers and back of her hands between the thumb and index finger.  These were several,  small fluid filled blisters that she could "pop" and were tender.  There was no rash, itching, shortness of breath, swelling anywhere on her body. There were no other blisters anywhere else on her body
pt recvd 1 dose of Engerix-B & the next day exp fever, nausea, vomiting, diarrhea & local swelling;
Few hours after injection (after clinic closed), patient had swelling lips, hives on opposite arm of injection. She was referred to ER by administration (clinic was closed). Patient later reported that she went to ER, did not receive any treatment, and was sent home without further problems.
shingles on my left leg; This case was reported by a consumer via interactive digital media and described the occurrence of shingles in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Concurrent medical conditions included decreased immune responsiveness (immune system might have been in a weakened state).   On an unknown date, the patient received Shingles vaccine. On an unknown date, 1 week after receiving Shingles vaccine, the patient experienced shingles. On an unknown date, the outcome of the shingles was unknown.   It was unknown if the reporter considered the shingles to be related to Shingles vaccine.  Additional details were provided as follows: The case was reported by the patient. The age at vaccination was not reported. The patient got the shingles vaccine shot and one week later, he/she developed shingles on his/her left leg.  The patient's physician said that no vaccine was 100 percent effect and stated that, his/her immune system might have been in a weakened state when he/she got the shot. The follow up would not possible as no contact details were available.
PATIENT FAINTED 5 MINUTES AFTER RECEIVING VACCINE.  HE ADMITTED BEFORE GETTING THE VACCINE THAT HE "DOESN'T LIKE SHOTS". WHEN HE CAME TO, HE WAS DIZZY, PALE/GRAYISH SKIN, VOMITED TWICE AND WAS FATIGUED. WE CALLED AN AMBULANCE. THE PARAMEDICS ATTENDED TO HIM AND ONCE HE WAS FEELING BETTER, HE REFUSED TO GO TO THE HOSPITAL.